Genmab A/S (GMAB)
After hours:
| Previous close | 26.93 |
| Open | 26.66 |
| Bid | 26.45 x 200 |
| Ask | 26.51 x 200 |
| Day's range | 26.28 - 26.70 |
| 52-week range | 24.53 - 38.80 |
| Volume | |
| Avg. volume | 602,359 |
| Market cap | 16.823B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 21.19 |
| EPS (TTM) | 1.25 |
| Earnings date | 06 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 39.40 |
GlobeNewswireCapital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 4,623 shares at DKK 1,025.00,3,656 shares at DKK 1,032.00,561 shares at DKK 1,050.00,1,645 shares at DKK 1,33
Insider MonkeyGenmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
Simply Wall St.Top High Growth Tech Stocks To Watch In August 2024
As global markets celebrate the Federal Reserve's announcement of impending interest rate cuts, small-cap stocks have outperformed their larger counterparts, buoyed by broad-based gains. In this dynamic environment, identifying high-growth tech stocks becomes crucial for investors looking to capitalize on market optimism and favorable economic conditions.
